W

Moderna’s stock doubles on promising cancer-vaccine results

Business Management
Share
Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Moderna’s stock doubles on promising cancer-vaccine results

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Building U.S. data centers is getting so expensive that AI companies are moving overseas

Public backlash, costs of power and cooler climates are among the reasons Big Tech is looking abroad for opportunities to build data centers. Source：MarketWatch

Wholesale inflation stirred up by Iran war and high oil prices. What does it mean for the Fed?

Wholesale costs in the U.S. jumped again in August, flogged by higher gasoline prices, in the first of two inflation reports that will dictate if the Federal…

Ex-BoE deputy governor headlines trio of former central bankers joining Fnality

Jon Cunliffe, Jochen Metzger and Ron Berndsen join Fnality Europe’s supervisory board as the company works to expand beyond its sterling payment system.…

Apple’s stock rises after iPhone reveal. The company is walking a ‘tightrope’ on pricing, say analysts.

Product launches show costconscious consumers remain a focus for the iPhone maker. Source：MarketWatch

Source：https://www.marketwatch.com/story/modernas-stock-doubles-on-promising-cancer-vaccine-results-896b1f2c